{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:37:04Z","timestamp":1773801424356,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1124\/jpet.102.040584","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:49:58Z","timestamp":1042224598000},"page":"1086-1094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Ocular Hypotensive Action of Topical Flunarizine in the Rabbit: Role of \u03c21 Recognition Sites"],"prefix":"10.1016","volume":"303","author":[{"given":"Gabriele","family":"Campana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Bucolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Murari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santi","family":"Spampinato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.040584_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0896-6273(02)00677-3","article-title":"The sigma receptor as a ligand-regulated auxiliary potassium channel subunit.","volume":"34","author":"Aydar","year":"2002","journal-title":"Neuron"},{"key":"10.1124\/jpet.102.040584_bib2","first-page":"882","article-title":"Modulation of (+)-[3H]pentazocine binding to guinea pig cerebellum by divalent cations.","volume":"42","author":"Basile","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.040584_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1353-8020(01)00006-2","article-title":"Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum.","volume":"8","author":"Belforte","year":"2001","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1124\/jpet.102.040584_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0304-3940(96)12711-7","article-title":"Intrasynaptsomal free calcium levels in rat forebrain synaptosomes: modulation by sigma (\u03c2) receptor ligands.","volume":"211","author":"Brent","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.102.040584_bib5","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-3565(24)38280-1","article-title":"\u03c21 recognition sites in rabbit iris-ciliary body: topical \u03c21-site agonists lower intraocular pressure.","volume":"289","author":"Bucolo","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.040584_bib6","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1523\/JNEUROSCI.09-10-03380.1989","article-title":"Sigma receptors inhibit contractions of the guinea pig ileum longitudinal muscle\/myenteric plexus preparation elicited by both electrical stimulation and exogenous serotonin.","volume":"9","author":"Campbell","year":"1989","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.102.040584_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0420.1997.tb00483.x","article-title":"The use of flunarizine in the management of low-tension glaucoma: a color Doppler study.","volume":"224","author":"Cellini","year":"1997","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"10.1124\/jpet.102.040584_bib8","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/j.1476-5381.1995.tb15929.x","article-title":"Blockade by sigma site ligands of high voltage-activated Ca2+ channels.","volume":"116","author":"Church","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.040584_bib9","doi-asserted-by":"crossref","first-page":"PL65","DOI":"10.1016\/0024-3205(92)90255-N","article-title":"Competitive interactions at [3H]1,3-di(2-tolyl)guanine (DTG)-defined \u03c2 recognition sites in guinea pig brain.","volume":"50","author":"DeHaven-Hudkins","year":"1992","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.040584_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0922-4106(92)90153-M","article-title":"Characterization of the binding of [3H](+)-pentazocine to \u03c2 recognition sites in guinea pig brain.","volume":"227","author":"DeHaven-Hudkins","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.040584_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-3623(94)00144-C","article-title":"The effects of various drugs on the myocardial inotropic response.","volume":"26","author":"Endoh","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.1124\/jpet.102.040584_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/PL00005076","article-title":"Release of [3H]dopamine from guinea pig striatal slices by sigma1 receptor agonist.","volume":"356","author":"Gonzalez","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/jpet.102.040584_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-8993(94)01394-W","article-title":"Sigma receptor regulation of norepinephrine release from rat hippocampal slices.","volume":"673","author":"Gonzalez-Alvear","year":"1995","journal-title":"Brain Res"},{"key":"10.1124\/jpet.102.040584_bib14","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning and expression of the mammalian sigma1-binding site.","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.040584_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.pharmtox.41.1.145","article-title":"Regulation and role of adenylyl cyclase isoforms.","volume":"41","author":"Hanoune","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.102.040584_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)39299-7","article-title":"Ca2+ signaling via \u03c21-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration.","volume":"293","author":"Hayashi","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.040584_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1073\/pnas.98.2.491","article-title":"Regulating ankyrin dynamics: roles of sigma-1 receptors.","volume":"98","author":"Hayashi","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.040584_bib18","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1073\/pnas.95.14.8381","article-title":"Novel paracrine signaling mechanism in the ocular ciliary epithelium.","volume":"95","author":"Hirata","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.040584_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-198427010-00002","article-title":"Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.","volume":"27","author":"Holmes","year":"1984","journal-title":"Drugs"},{"key":"10.1124\/jpet.102.040584_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(00)00774-3","article-title":"Evidence that the sigma(1) receptor is not directly coupled to G proteins.","volume":"408","author":"Hong","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.040584_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/02713688608996371","article-title":"Potentiation of sympathetic neurosecretion by forskolin and cyclic AMP in the rabbit iris-ciliary body.","volume":"5","author":"Jumblatt","year":"1986","journal-title":"Curr Eye Res"},{"key":"10.1124\/jpet.102.040584_bib22","series-title":"Pharmacology of the Eye","first-page":"149","article-title":"Cholinergics","author":"Kaufman","year":"1984"},{"key":"10.1124\/jpet.102.040584_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.pa.26.040186.002153","article-title":"Observations on the pharmacology of glaucoma.","volume":"26","author":"Leopold","year":"1986","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.102.040584_bib24","series-title":"Pharmacology of the Eye","first-page":"249","article-title":"Autonomic nervous system: adrenergic antagonists","author":"Lotti","year":"1984"},{"key":"10.1124\/jpet.102.040584_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0022-3565(24)37192-7","article-title":"The effect of topical diltiazem on intraocular pressure in betamethasone-induced ocular hypertensive rabbits.","volume":"284","author":"Melena","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.040584_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000310630","article-title":"Measurement of rabbit intraocular pressure with the Tono-Pen.","volume":"209","author":"Mermoud","year":"1995","journal-title":"Ophthalmologica"},{"key":"10.1124\/jpet.102.040584_bib27","first-page":"317","article-title":"Ca2+\/calmodulin effects on cAMP response in cultured chick ciliary epithelial cells.","volume":"39","author":"Mishima","year":"1995","journal-title":"Jpn J Ophthalmol"},{"key":"10.1124\/jpet.102.040584_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/exer.2001.1022","article-title":"Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation.","volume":"73","author":"Moore","year":"2001","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.102.040584_bib29","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1073\/pnas.96.14.8196","article-title":"Intracellular \u03c21 receptor modulates phospholipase C and protein kinase C activities in the brainstem.","volume":"96","author":"Morin-Surun","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.040584_bib30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0002-9394(14)71458-8","article-title":"Calcium channel blockers in the management of low-tension and open-angle glaucoma.","volume":"115","author":"Netland","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1124\/jpet.102.040584_bib31","first-page":"525","article-title":"The identification of adrenergic and cholinergic nerve endings in the trabecular meshwork.","volume":"13","author":"Nomura","year":"1974","journal-title":"Investig Ophthalmol"},{"key":"10.1124\/jpet.102.040584_bib32","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0022-3565(25)38837-3","article-title":"Ocular action of moxonidine: a possible role for imidazoline receptors.","volume":"269","author":"Ogidigben","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.040584_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000058042","article-title":"Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE and cAMP levels in rabbit eyes.","volume":"65","author":"Ogidigben","year":"2002","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.102.040584_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0169-328X(01)00249-2","article-title":"Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina.","volume":"95","author":"Ola","year":"2001","journal-title":"Mol Brain Res"},{"key":"10.1124\/jpet.102.040584_bib35","first-page":"1456","article-title":"Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity.","volume":"43","author":"Osborne","year":"2002","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.102.040584_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-6147(92)90030-A","article-title":"A proposal for the classification of sigma binding sites.","volume":"13","author":"Quiron","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.040584_bib37","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/0024-3205(91)90220-6","article-title":"Ca2+ and Na+ channels involved in neuronal cell death. Protection by flunarizine.","volume":"48","author":"Pauwels","year":"1991","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.040584_bib38","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-3565(24)29460-X","article-title":"Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine.","volume":"298","author":"Russell","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.040584_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0922-4106(94)90155-4","article-title":"Calcium channel blockers inhibit the (Ca2+-Mg2+)-ATPase activity and [125I]calmodulin binding in brain membranes.","volume":"267","author":"Santos","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.040584_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-9394(74)90744-2","article-title":"Blood aqueous barrier and alpha-chymotrypsin glaucoma in rabbits.","volume":"77","author":"Sears","year":"1974","journal-title":"Am J Ophthalmol"},{"key":"10.1124\/jpet.102.040584_bib41","series-title":"Pharmacology of the Eye","first-page":"193","article-title":"Autonomic nervous system: Adrenergic agonists","author":"Sears","year":"1984"},{"key":"10.1124\/jpet.102.040584_bib42","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0306-3623(93)90364-4","article-title":"The topical application of verapamil and nifedipine lowers intraocular pressure in conscious rabbits.","volume":"24","author":"Segarra","year":"1993","journal-title":"Gen Pharmacol"},{"key":"10.1124\/jpet.102.040584_bib43","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1006\/exer.1996.0272","article-title":"The presence of \u03c2 receptor subtypes in bovine retinal membranes.","volume":"64","author":"Senda","year":"1997","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.102.040584_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00061198-200008000-00009","article-title":"Effect of calcium channel blockers alone and in combination with antiglaucoma medications on intraocular pressure in the primate eye.","volume":"9","author":"Siegner","year":"2000","journal-title":"J Glaucoma"},{"key":"10.1124\/jpet.102.040584_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0165-6147(99)01307-3","article-title":"G protein regulation of adenylate cyclase.","volume":"20","author":"Simonds","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.040584_bib46","series-title":"The Sigma Receptors, Neuroscience Perspectives Series","first-page":"21","article-title":"Sigma receptors in the central nervous system and the periphery","author":"Su","year":"1994"},{"key":"10.1124\/jpet.102.040584_bib47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF00233243","article-title":"Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea pig brain membranes.","volume":"351","author":"Tanaka","year":"1995","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/jpet.102.040584_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0031-6997(25)00047-X","article-title":"Sigma receptors: biology and function.","volume":"42","author":"Walker","year":"1990","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.102.040584_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(98)01175-5","article-title":"Pharmacological interaction of the calcium channel blockers verapamil and flunarizine with the opioid system.","volume":"818","author":"Weizman","year":"1999","journal-title":"Brain Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524360446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524360446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.040584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:32:12Z","timestamp":1740007932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524360446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0022356524360446"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.040584","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Hypotensive Action of Topical Flunarizine in the Rabbit: Role of \u03c21 Recognition Sites","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.040584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}